One-year functional and structural effects of mavacamten in obstructive hypertrophic cardiomyopathy: a comprehensive CMR study
- PMID: 40796166
- DOI: 10.1093/ehjci/jeaf231
One-year functional and structural effects of mavacamten in obstructive hypertrophic cardiomyopathy: a comprehensive CMR study
Conflict of interest statement
Conflict of interest: K.S.: Speakers bureau, Bristol Myers Squibb. R.P.: Speakers bureau, Bristol Myers Squibb. R.J.G.: Speakers bureau, Philips Healthcare. Speakers bureau, Guerbet GmbH. H.T.F.: Speakers bureau, Guerbet GmbH, Speakers bureau, Bristol Myers Squibb. D.M.: Speakers bureau, Philips Healthcare. L.P.: Speakers bureau, Philips Healthcare. Speakers bureau, Guerbet GmbH. The remaining authors have no relationships relevant to the contents of this paper to disclose.
LinkOut - more resources
Full Text Sources
